Fatemeh Ardeshir-Larijani, Patrick J. Loehrer, R. Maniar, T. Hou, Victoria DeBrock, H. Mesa
{"title":"AB025.评估胸腺上皮肿瘤微阵列中实验性或 FDA 批准疗法的潜在治疗免疫组化靶点","authors":"Fatemeh Ardeshir-Larijani, Patrick J. Loehrer, R. Maniar, T. Hou, Victoria DeBrock, H. Mesa","doi":"10.21037/med-23-ab025","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":502794,"journal":{"name":"Mediastinum","volume":"21 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AB025. Evaluation of potential therapeutic immunohistochemical targets with experimental or FDA-approved therapies in thymic epithelial tumor microarrays\",\"authors\":\"Fatemeh Ardeshir-Larijani, Patrick J. Loehrer, R. Maniar, T. Hou, Victoria DeBrock, H. Mesa\",\"doi\":\"10.21037/med-23-ab025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":502794,\"journal\":{\"name\":\"Mediastinum\",\"volume\":\"21 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mediastinum\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21037/med-23-ab025\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mediastinum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/med-23-ab025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
AB025. Evaluation of potential therapeutic immunohistochemical targets with experimental or FDA-approved therapies in thymic epithelial tumor microarrays